메뉴 건너뛰기




Volumn 55, Issue 4, 2011, Pages 747-749

Drug induced liver injury and its relationship to autoimmune hepatitis

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; FLUCLOXACILLIN; HALOTHANE; IMMUNOSUPPRESSIVE AGENT; LIVER ANTIGEN; LIVER ENZYME; MINOCYCLINE; NITROFURANTOIN; PARACETAMOL; STEROID;

EID: 80052929533     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.02.024     Document Type: Editorial
Times cited : (91)

References (19)
  • 1
    • 57249086242 scopus 로고    scopus 로고
    • Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States
    • e1921-1924
    • N. Chalasani, R.J. Fontana, H.L. Bonkovsky, P.B. Watkins, T. Davern, and J. Serrano Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States Gastroenterology 135 2008 1924 1934 e1921-1924
    • (2008) Gastroenterology , vol.135 , pp. 1924-1934
    • Chalasani, N.1    Fontana, R.J.2    Bonkovsky, H.L.3    Watkins, P.B.4    Davern, T.5    Serrano, J.6
  • 2
    • 20844444779 scopus 로고    scopus 로고
    • Idiosyncratic drug hepatotoxicity
    • DOI 10.1038/nrd1750
    • N. Kaplowitz Idiosyncratic drug hepatotoxicity Nat Rev Drug Discov 4 2005 489 499 (Pubitemid 40861991)
    • (2005) Nature Reviews Drug Discovery , vol.4 , Issue.6 , pp. 489-499
    • Kaplowitz, N.1
  • 3
    • 0036086775 scopus 로고    scopus 로고
    • Diabetes increases the risk of acute hepatic failure
    • H.B. El-Serag, and J.E. Everhart Diabetes increases the risk of acute hepatic failure Gastroenterology 122 2002 1822 1828 (Pubitemid 34651427)
    • (2002) Gastroenterology , vol.122 , Issue.7 , pp. 1822-1828
    • ElSerag, H.B.1    Everhart, J.E.2
  • 4
    • 59349097386 scopus 로고    scopus 로고
    • The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice
    • E. Bjornsson, and L. Davidsdottir The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice J Hepatol 50 2009 511 517
    • (2009) J Hepatol , vol.50 , pp. 511-517
    • Bjornsson, E.1    Davidsdottir, L.2
  • 5
    • 77953210655 scopus 로고    scopus 로고
    • Review article: Drug-induced liver injury in clinical practice
    • E. Bjornsson Review article: drug-induced liver injury in clinical practice Aliment Pharmacol Ther 32 2010 3 13
    • (2010) Aliment Pharmacol Ther , vol.32 , pp. 3-13
    • Bjornsson, E.1
  • 6
    • 75449112589 scopus 로고    scopus 로고
    • Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events
    • C. Lammert, E. Bjornsson, A. Niklasson, and N. Chalasani Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events Hepatology 51 2010 615 620
    • (2010) Hepatology , vol.51 , pp. 615-620
    • Lammert, C.1    Bjornsson, E.2    Niklasson, A.3    Chalasani, N.4
  • 7
    • 33947204690 scopus 로고    scopus 로고
    • Mitochondrial abnormalities-A link to idiosyncratic drug hepatotoxicity?
    • DOI 10.1016/j.taap.2006.12.013, PII S0041008X06004856
    • U.A. Boelsterli, and P.L. Lim Mitochondrial abnormalities - a link to idiosyncratic drug hepatotoxicity? Toxicol Appl Pharmacol 220 2007 92 107 (Pubitemid 46427861)
    • (2007) Toxicology and Applied Pharmacology , vol.220 , Issue.1 , pp. 92-107
    • Boelsterli, U.A.1    Lim, P.L.K.2
  • 8
    • 49649102889 scopus 로고    scopus 로고
    • Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury
    • M.I. Lucena, R.J. Andrade, C. Martinez, E. Ulzurrun, E. Garcia-Martin, and Y. Borraz Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury Hepatology 48 2008 588 596
    • (2008) Hepatology , vol.48 , pp. 588-596
    • Lucena, M.I.1    Andrade, R.J.2    Martinez, C.3    Ulzurrun, E.4    Garcia-Martin, E.5    Borraz, Y.6
  • 9
    • 78649615066 scopus 로고    scopus 로고
    • Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: A systematic review
    • C.M. Hunt Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury: a systematic review Hepatology 52 2010 2216 2222
    • (2010) Hepatology , vol.52 , pp. 2216-2222
    • Hunt, C.M.1
  • 10
    • 77749245930 scopus 로고    scopus 로고
    • Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity
    • S.K. Sharma, R. Singla, P. Sarda, A. Mohan, G. Makharia, and A. Jayaswal Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity Clin Infect Dis 50 2010 833 839
    • (2010) Clin Infect Dis , vol.50 , pp. 833-839
    • Sharma, S.K.1    Singla, R.2    Sarda, P.3    Mohan, A.4    Makharia, G.5    Jayaswal, A.6
  • 16
    • 34848918187 scopus 로고    scopus 로고
    • The significance of autoantibodies and immunoglobulins in acute liver failure: A cohort study
    • DOI 10.1016/j.jhep.2007.05.011, PII S0168827807003157
    • W. Bernal, Y. Ma, H.M. Smith, B. Portmann, J. Wendon, and D. Vergani The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study J Hepatol 47 2007 664 670 (Pubitemid 47503423)
    • (2007) Journal of Hepatology , vol.47 , Issue.5 , pp. 664-670
    • Bernal, W.1    Ma, Y.2    Smith, H.M.3    Portmann, B.4    Wendon, J.5    Vergani, D.6
  • 17
    • 78649572324 scopus 로고    scopus 로고
    • Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor alpha agents
    • C. Efe, T. Purnak, E. Ozaslan, and S. Wahlin Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor alpha agents Hepatology 52 2010 2246 2247
    • (2010) Hepatology , vol.52 , pp. 2246-2247
    • Efe, C.1    Purnak, T.2    Ozaslan, E.3    Wahlin, S.4
  • 18
    • 49349102446 scopus 로고    scopus 로고
    • Unmasking autoimmune Hepatitis under immunomodulatory treatment of multiple sclerosis - Not only beta interferon
    • V. von Kalckreuth, A.W. Lohse, and C. Schramm Unmasking autoimmune Hepatitis under immunomodulatory treatment of multiple sclerosis - not only beta interferon Am J Gastroenterol 103 2008 2147 2148
    • (2008) Am J Gastroenterol , vol.103 , pp. 2147-2148
    • Von Kalckreuth, V.1    Lohse, A.W.2    Schramm, C.3
  • 19
    • 78049469917 scopus 로고    scopus 로고
    • Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury
    • P.T. Donaldson, A.K. Daly, J. Henderson, J. Graham, M. Pirmohamed, and W. Bernal Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury J Hepatol 53 2010 1049 1053
    • (2010) J Hepatol , vol.53 , pp. 1049-1053
    • Donaldson, P.T.1    Daly, A.K.2    Henderson, J.3    Graham, J.4    Pirmohamed, M.5    Bernal, W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.